Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Montgomery

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
The Australian and New Zealand Journal of Psychiatry|November 14, 2007
Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: outcomesJayashri Kulkarni, Anthony R de Castella, Kate M Filia, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|August 24, 2016
Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthoodTamás Treuer, Kwok Ling Phyllis Chan, Bung Nyun Kim, et al.
Neuropsychiatric Disease and Treatment|July 18, 2014
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?William Montgomery, Tamas Treuer, Wenyu Ye, et al.
Journal of Affective Disorders|September 25, 2007
The Bipolar Comprehensive Outcomes Study (BCOS): baseline findings of an Australian cohort studyJayashri Kulkarni, Michael Berk, Paul B Fitzgerald, et al.
Patient Preference and Adherence|September 23, 2010
Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherenceKatarina Kelin, Alan Jm Brnabic, Richard Newton, et al.
Journal of Child and Adolescent Psychopharmacology|April 9, 2013
A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerabilityTamás Treuer, Susan Shur-Fen Gau, Luis Méndez, et al.
BMC Psychiatry|September 28, 2011
Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophreniaHaya Ascher-Svanum, Fangyi Zhao, Holland C Detke, et al.
Frontiers in Psychology|July 29, 2025
Effects of psychology teachers' didactic performance on student didactic performanceWalter Capa-Luque, Aldo Bazán-Ramírez, Luz Elizabeth Mayorga-Falcón, et al.
Patient Preference and Adherence|June 11, 2011
Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherenceKatarina Kelin, Timothy Lambert, Alan Jm Brnabic, et al.
The Journal of Surgical Research|November 9, 2019
Female Mice Exhibit Abdominal Aortic Aneurysm Protection in an Established Rupture ModelAnna Z Fashandi, Michael Spinosa, Morgan Salmon, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
The Australian and New Zealand Journal of Psychiatry|November 14, 2007
Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: outcomesJayashri Kulkarni, Anthony R de Castella, Kate M Filia, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|August 24, 2016
Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthoodTamás Treuer, Kwok Ling Phyllis Chan, Bung Nyun Kim, et al.
Neuropsychiatric Disease and Treatment|July 18, 2014
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?William Montgomery, Tamas Treuer, Wenyu Ye, et al.
Journal of Affective Disorders|September 25, 2007
The Bipolar Comprehensive Outcomes Study (BCOS): baseline findings of an Australian cohort studyJayashri Kulkarni, Michael Berk, Paul B Fitzgerald, et al.
Patient Preference and Adherence|September 23, 2010
Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherenceKatarina Kelin, Alan Jm Brnabic, Richard Newton, et al.
Journal of Child and Adolescent Psychopharmacology|April 9, 2013
A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerabilityTamás Treuer, Susan Shur-Fen Gau, Luis Méndez, et al.
BMC Psychiatry|September 28, 2011
Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophreniaHaya Ascher-Svanum, Fangyi Zhao, Holland C Detke, et al.
Frontiers in Psychology|July 29, 2025
Effects of psychology teachers' didactic performance on student didactic performanceWalter Capa-Luque, Aldo Bazán-Ramírez, Luz Elizabeth Mayorga-Falcón, et al.
Patient Preference and Adherence|June 11, 2011
Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherenceKatarina Kelin, Timothy Lambert, Alan Jm Brnabic, et al.
The Journal of Surgical Research|November 9, 2019
Female Mice Exhibit Abdominal Aortic Aneurysm Protection in an Established Rupture ModelAnna Z Fashandi, Michael Spinosa, Morgan Salmon, et al.
Pageof 9